News
In this article, we are going to take a look at where Cassava Sciences, Inc. (NASDAQ:SAVA) stands against other best short-term stocks with a buying opportunity for investors. Thrilling highs ...
SAVA has a new potential indication for simufilam ... The Company also outlined its plan to discontinue the Phase 3 REFOCUS-ALZ study and Open Label Extension study and to analyze the complete ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results